The Estee Lauder Companies and OXIS International Resolve Dispute (EL)

OXIS INTERNATIONAL, INC. (OXIS) and THE ESTEE LAUDER COMPANIES INC. EL announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria." An agreement between the parties provides Oxis with full title to the '746 and '533 Patents in exchange for Estee Lauder receiving a non-exclusive license under the '746 and '533 Patents within the cosmetic market. The material terms and conditions are to remain confidential pursuant to the agreement.